Lifestyle Choices Fuel Epidemics of Diabetes and Cardiovascular Disease Among Asian Indians

Progress in Cardiovascular Diseases

Volumn 58, Issue 5, 2016, Pages 505-513

  O'Keefe, Evan L ^a,b   DiNicolantonio, James J ^c   Patil, Harshal ^c   Helzberg, John H ^d   Lavie, Carl J ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Coronary artery disease; Exercise; Metabolic syndrome; Sugar; Type 2 diabetes mellitus; Vitamin D

Indexed keywords

YOGHURT; POLLUTANT;

AIR POLLUTION; ARTICLE; BEVERAGE; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ECONOMIC ASPECT; EPIDEMIC; ETHNIC DIFFERENCE; EUROPEAN; EXERCISE; FATTY LIVER; GRAIN; HIGH RISK POPULATION; HUMAN; INDIA; INDIAN; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUT; OBESITY; PHYSICAL INACTIVITY; PREVALENCE; PRIMARY PREVENTION; RISK FACTOR; SEDENTARY LIFESTYLE; SMOKING; VITAMIN D DEFICIENCY; ADVERSE EFFECTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; DIET; EPIDEMIOLOGY; ETHNOLOGY; FEEDING BEHAVIOR; MORTALITY; NUTRITIONAL STATUS; POLLUTANT; PROGNOSIS; RISK ASSESSMENT; RISK REDUCTION; TIME FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIET; ENVIRONMENTAL POLLUTANTS; EPIDEMICS; FEEDING BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INDIA; LIFE STYLE; NUTRITIONAL STATUS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEDENTARY LIFESTYLE; SMOKING; TIME FACTORS; VITAMIN D DEFICIENCY;

EID: 84950109148     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.08.010     Document Type: Article

References (87)

1. Yusuf S., Rangarajan S., Teo K., et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 2014, 371(9):818-827.
2. Center PR Attitudes about aging: a global perspective 2014, Pew Research Center, Washington, DC.
3. Institute MP Indian immigrants in the United States 2013, Migration Policy Institute, Washington, DC.
4. Kanaya A.M., Wassel C.L., Mathur D., et al. Prevalence and correlates of diabetes in South Asian Indians in the United States: findings from the metabolic syndrome and atherosclerosis in South Asians living in America study and the multi-ethnic study of atherosclerosis. Metab Syndr Relat Disord 2010, 8(2):157-164.
5. Joshi P., Islam S., Pais P., et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007, 297(3):286-294.
6. Prabhakaran D., Yusuf S. Cardiovascular disease in India: lessons learnt & challenges ahead. Indian J Med Res 2010, 132:529-530.
7. Tan S.T., Scott W., Panoulas V., et al. Coronary heart disease in Indian Asians. Glob Cardiol Sci Pract 2014, 2014(1):13-23.
8. Bloom D.E., Cafiero-Fonseca E.T., Candeias V., et al. Economics of non-communicable diseases in India: the costs and returns on investment of interventions to promote healthy living and prevent, treat, and manage NCDs 2014, Harvard School of Public Health, Boston.
9. Goswami R. India's population in 2050: extreme projections demand extreme actions. East Asia Forum 2013, [http://www.eastasiaforum.org/2013/04/05/indias-population-in-2050-extreme-projections-demand-extreme-action/].
10. Gupta R., Joshi P., Mohan V., Reddy K.S., Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart 2008, 94(1):16-26.
11. Dutta S. The cost of India's heart disease epidemic is over $2 trillion. Quartz India 2014, [http://qz.com/292222. Accessed December 31, 2014].
12. Gupta M., Singh N., Verma S. South Asians and cardiovascular risk: what clinicians should know. Circulation 2006, 113(25):e924-e929.
13. Goff D.C., Lloyd-Jones D.M., Bennett G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014, 63(25 Pt B):2935-2959.
14. NHLBI Morbidity & mortality: chart book on cardiovascular, lung, and blood diseases 2012, National Heart, Lung, and Blood Institute, Bethesda.
15. Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127(1):e6-e245.
16. Misra A., Ramchandran A., Jayawardena R., Shrivastava U., Snehalatha C. Diabetes in South Asians. Diabet Med 2014, 31(10):1153-1162.
17. Chauhan S., Aeri B.T. Prevalence of cardiovascular disease in India and its economic impact-a review. IJSRP 2013, 3(10):1-5.
18. Gaziano T.A. Is the horse already out of the barn in rural India?. Circulation 2009, 119(14):1850-1852.
19. Kaveeshwar S.A., Cornwall J. The current state of diabetes mellitus in India. Australas Med J 2014, 7(1):45-48.
20. Scully T. Diabetes in numbers. Nature 2012, 485(7398):S2-S3.
21. Statistics NCfH Health, United States, 2013: with special feature on prescription drugs 2014, 511. U.S. Department of Health and Human Services, Hyattsville. Services USDoHaH (Ed.).
22. DiNicolantonio J.J., O'Keefe J.H., Lucan S.C. Added fructose: a principal driver of type 2 diabetes and its consequences. Mayo Clin Proc 2015, 90:372-381.
23. Basu S., Yoffe P., Hills N., Lustig R.H. The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One 2013, 8(2):e57873.
24. Misra A., Khurana L., Isharwal S., Bhardwaj S. South Asian diets and insulin resistance. Br J Nutr 2009, 101(4):465-473.
25. Shetty P. Public health: India's diabetes time bomb. Nature 2012, 485(7398):S14-S16.
26. Stanhope K.L., Schwarz J.M., Keim N.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119(5):1322-1334.
27. OECD Obesity update. OECD Health Statistics 2014 2014, OECD, [http://www.oecd.org/els/health-systems/Obesity-Update-2014.pdf].
28. Pratyush D.D., Tiwari S., Singh S., Singh S.K. Waist circumference cutoff and its importance for diagnosis of metabolic syndrome in Asian Indians: a preliminary study. Indian J Endocrinol Metab 2012, 16(1):112-115.
29. Chhabra R., O'Keefe J.H., Patil H., et al. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. Mayo Clin Proc 2013, 88(11):1259-1265.
30. Barnes E. Fatty liver disease occurs with risky plaque 2014, AuntMinnie.com. AuntMinnie.com (Ed.).
31. Kalra S., Vithalani M., Gulati G., et al. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India 2013, 61(7):448-453.
32. Lazo M., Hernaez R., Eberhardt M.S., et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2013, 178(1):38-45.
33. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40(6):1387-1395.
34. Lazo M., Clark J.M. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008, 28(4):339-350.
35. Lopez-Velazquez J.A., Silva-Vidal K.V., Ponciano-Rodriguez G., et al. The prevalence of nonalcoholic fatty liver disease in the Americas. Ann Hepatol 2014, 13(2):166-178.
36. Science D Update on new treatments for liver diseases. Featured Research 2014, [www.sciencedaily.com/releases/2014/2011/141121102825.htm, accessed January 14, 2015].
37. RGI/CGHR Special fertility & mortality survey, 1998. A report of 1.1 million Indian households 2005, Registrar General, New Delhi.
38. Jha P., Jacob B., Gajalakshmi V., et al. A nationally representative case-control study of smoking and death in India. N Engl J Med 2008, 358(11):1137-1147.
39. Greenstone M., Nilekani J., Pande R., Ryan N., Sudarshan A., Sugathan A. Lower pollution, longer lives: life expectancy gains if India reduced particulate matter pollution. Econ Pol Wkly 2015, L(8):40-46.
40. Lavie C.J., McAuley P.A., Church T.S., Milani R.V., Blair S.N. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014, 63(14):1345-1354.
41. Church T.S., Thomas D.M., Tudor-Locke C., et al. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS One 2011, 6(5):e19657.
42. Archer E., Shook R.P., Thomas D.M., et al. 45-Year trends in women's use of time and household management energy expenditure. PLoS One 2013, 8(2):e56620.
43. Archer E., Lavie C.J., McDonald S.M., et al. Maternal inactivity: 45-year trends in mothers' use of time. Mayo Clin Proc 2013, 88(12):1368-1377.
44. Guthold R., Ono T., Strong K.L., Chatterji S., Morabia A. Worldwide variability in physical inactivity a 51-country survey. Am J Prev Med 2008, 34(6):486-494.
45. Anjana R.M., Pradeepa R., Das A.K., et al. Physical activity and inactivity patterns in India-results from the ICMR-INDIAB study (Phase-1) [ICMR-INDIAB-5]. Int J Behav Nutr Phys Act 2014, 11(1):26.
46. Mehlawat U., Singh P., Pande S. Current status of Vitamin-D deficiency in India. Innov Pharm Pharmacother 2014, 2(2):328-335.
47. Kunadian V., Ford G.A., Bawamia B., Qiu W., Manson J.E. Vitamin D deficiency and coronary artery disease: a review of the evidence. Am Heart J 2014, 167(3):283-291.
48. Young K.A., Snell-Bergeon J.K., Naik R.G., et al. Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care 2011, 34(2):454-458.
49. Talaei A., Mohamadi M., Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 2013, 5(1):8.
50. O'Keefe J.H., Lavie C.J., Holick M.F. Vitamin D supplementation for cardiovascular disease prevention. JAMA 2011, 306(14):1546-1547. [author reply 1547-1548].
51. Gulati S., Misra A. Sugar intake, obesity, and diabetes in India. Nutrients 2014, 6(12):5955-5974.
52. Yang Q., Zhang Z., Gregg E.W., Flanders W.D., Merritt R., Hu F.B. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med 2014, 174(4):516-524.
53. Weeratunga P., Jayasinghe S., Perera Y., Jayasena G. Per capita sugar consumption and prevalence of diabetes mellitus-global and regional associations. BMC Public Health 2014, 14:186.
54. Joshi S.R., Bhansali A., Bajaj S., et al. Results from a dietary survey in an Indian T2DM population: a STARCH study. BMJ Open 2014, 4(10):e005138.
55. Lim C., Tan S. 1 every 6 seconds. Saatchi & Saatchi Sri Lanka spreads the shocking truth about diabetes 2014, Saatchi & Saatchi Worldwide. S. Saatchi (Ed.).
56. Moynihan P.J., Kelly S.A. Effect on caries of restricting sugars intake: systematic review to inform WHO guidelines. J Dent Res 2014, 93(1):8-18.
57. Te Morenga L., Mallard S., Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 2013, 346:e7492.
58. Cordain L., Eades M.R., Eades M.D. Hyperinsulinemic diseases of civilization: more than just syndrome X. Comp Biochem Physiol A Mol Integr Physiol 2003, 136(1):95-112.
59. Marriott B.P., Olsho L., Hadden L., Connor P. Intake of added sugars and selected nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003-2006. Crit Rev Food Sci Nutr 2010, 50(3):228-258.
60. Misra A., Sharma R., Gulati S., et al. Consensus dietary guidelines for healthy living and prevention of obesity, the metabolic syndrome, diabetes, and related disorders in Asian Indians. Diabetes Technol Ther 2011, 13(6):683-694.
61. Health OW WHO opens public consultation on draft sugars guideline 2014, World Health Organization, Geneva.
62. UK THP Recommended sugar intake: which country eats the most sugar in the world?. HuffPost LIfestyle 2014, Huffington Post. R. Moss (Ed.).
63. DiNicolantonio J.J., O'Keefe J.H., Lucan S.C. An unsavory truth: sugar, more than salt, predisposes to hypertension and chronic disease. Am J Cardiol 2014, 114(7):1126-1128.
64. Romaguera D., Norat T., Wark P.A., et al. Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 2013, 56(7):1520-1530.
65. Malik V.S., Popkin B.M., Bray G.A., Despres J.P., Willett W.C., Hu F.B. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010, 33(11):2477-2483.
66. de Koning L., Malik V.S., Kellogg M.D., Rimm E.B., Willett W.C., Hu F.B. Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation 2012, 125(14):1735-1741. [S1731].
67. Fung T.T., Malik V., Rexrode K.M., Manson J.E., Willett W.C., Hu F.B. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr 2009, 89(4):1037-1042.
68. Sievenpiper J.L., de Souza R.J., Mirrahimi A., et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 2012, 156(4):291-304.
69. Livesey G., Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008, 88(5):1419-1437.
70. Cozma A.I., Sievenpiper J.L., de Souza R.J., et al. Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care 2012, 35(7):1611-1620.
71. Wang D.D., Sievenpiper J.L., de Souza R.J., et al. Effect of fructose on postprandial triglycerides: a systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 2014, 232(1):125-133.
72. Ha V., Sievenpiper J.L., de Souza R.J., et al. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 2012, 59(4):787-795.
73. Chiu S., Sievenpiper J.L., de Souza R.J., et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 2014, 68(4):416-423.
74. Egli L., Lecoultre V., Theytaz F., et al. Exercise prevents fructose-induced hypertriglyceridemia in healthy young subjects. Diabetes 2013, 62(7):2259-2265.
75. van Buul V.J., Tappy L., Brouns F.J. Misconceptions about fructose-containing sugars and their role in the obesity epidemic. Nutr Res Rev 2014, 27(1):119-130.
76. Viguiliouk E., Kendall C.W., Blanco Mejia S., et al. Effect of tree nuts on glycemic control in diabetes: a systematic review and meta-analysis of randomized controlled dietary trials. PLoS One 2014, 9(7):e103376.
77. Estruch R., Ros E., Salas-Salvado J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013, 368(14):1279-1290.
78. Bao Y., Han J., Hu F.B., et al. Association of nut consumption with total and cause-specific mortality. N Engl J Med 2013, 369(21):2001-2011.
79. Gulati S., Misra A., Pandey R.M., Bhatt S.P., Saluja S. Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: a 24-wk, randomized control trial. Nutrition 2014, 30(2):192-197.
80. Good D., Lavie C.J., Ventura H.O. Dietary intake of nuts and cardiovascular prognosis. Ochsner J 2009, 9(1):32-36.
81. Chen M., Sun Q., Giovannucci E., et al. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med 2014, 12:215.
82. Group WB Poverty headcount ratio at $2 a day (PPP) (% of population). World Development Indicators 2014, [http://data.worldbank.org/indicator/SI.POV.2DAY. Accessed January 8, 2015].
83. Basu S., Vellakkal S., Agrawal S., Stuckler D., Popkin B., Ebrahim S. Averting obesity and type 2 diabetes in India through sugar-sweetened beverage taxation: an economic-epidemiologic modeling study. PLoS Med 2014, 11(1):e1001582.
84. Pratt M., Perez L.G., Goenka S., et al. Can population levels of physical activity be increased? Global evidence and experience. Prog Cardiovasc Dis 2015, 57(4):356-367.
85. Hills A.P., Dengel D.R., Lubans D.R. Supporting public health priorities: recommendations for physical education and physical activity promotion in schools. Prog Cardiovasc Dis 2015, 57(4):368-374.
86. Sallis R., Franklin B., Joy L., Ross R., Sabgir D., Stone J. Strategies for promoting physical activity in clinical practice. Prog Cardiovasc Dis 2015, 57(4):375-386.
87. Economics T India GDP 1970-2014. Trading economics 2014, [http://www.tradingeconomics.com/india/gdp].